Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
dutrebis
merck sharp dohme limited - lamivudin, raltegravir kalium - hiv infektioner - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - dutrebis angives i kombination med andre anti‑retroviral lægemidler til behandling af human immundefekt virus (hiv‑1) infektion hos voksne, unge og børn i alderen fra 6 år og vejer mindst 30 kg uden nuværende eller tidligere bevis for viral modstandsdygtigheden over for antivirale stoffer af insti (integrase strand overføre hæmmer) og nrti (nucleoside reverse transkriptase hæmmer) klasser (se afsnit 4. 2, 4. 4 og 5.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv infektioner - antivirale midler til systemisk anvendelse - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infektioner - antivirale midler til systemisk anvendelse - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
apretude
viiv healthcare b.v. - cabotegravir - hiv infektioner - antivirale midler til systemisk anvendelse - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 og 5.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
biktarvy
gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarate - hiv infektioner - antivirale midler til systemisk anvendelse - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (se afsnit 5.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
dovato
viiv healthcare b.v. - dolutegravir natrium, lamivudin - hiv infektioner - antivirale midler til systemisk anvendelse - dovato er indiceret til behandling af human immundefekt virus type 1 (hiv-1) infektion hos voksne og unge over 12 år, som vejer mindst 40 kg, og som er uden kendt eller formodet resistens over for integrase inhibitor klasse, eller lamivudin.
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
darunavir "sandoz" 75 mg filmovertrukne tabletter
sandoz a/s - darunavir - filmovertrukne tabletter - 75 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
darunavir "teva" 400 mg filmovertrukne tabletter
teva b.v. - darunavirethanolat - filmovertrukne tabletter - 400 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
darunavir "teva" 600 mg filmovertrukne tabletter
teva b.v. - darunavirethanolat - filmovertrukne tabletter - 600 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
davarino 150 mg filmovertrukne tabletter
pharmathen s.a. - darunavirpropylenglycolat - filmovertrukne tabletter - 150 mg